- Status:
- In progress
- Decision:
- Prioritised
- Process:
- TA
- ID number:
- 1056
Project Team
- Project lead
- Kate Moore
Email enquiries
If you have any queries please email TACommD@nice.org.uk
Stakeholders
- Companies sponsors
- Bayer
- Others
- Department of Health
- NHS England
- Welsh Government
- Patient carer groups
- GIST Support Group
- Sarcoma UK
- Professional groups
- Cancer Research UK
- Royal College of Physicians
- Royal College of Radiologists
- General commentators
- All Wales Therapeutics and Toxicology Centre
- British National Formulary
- Department of Health, Social Services and Public Safety for Northern Ireland
- Healthcare Improvement Scotland
- Welsh Health Specialised Services Committee
- Relevant research groups
- Institute of Cancer Research
- National Cancer Research Institute
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 15 November 2017 | Expected publication |
| 12 October 2017 - 26 October 2017 | Final appraisal determination |
| 30 August 2017 | Committee meeting: 2 |
| 02 August 2017 | Note added to the project documents |
| 28 June 2017 | Committee meeting: 1 |
| 20 January 2017 | Invitation to participate |
| 20 September 2016 | Draft scope documents |
| 08 June 2016 | Referral |
For further information on our processes and methods, please see our CHTE processes and methods manual